Subscribe To Our Free Newsletter |
Aurobindo Pharma’s Rajasthan-based facility concludes US FDA audit with 9 observations
Aurobindo Pharma said that the United States Food and Drug Administration (US FDA) inspected the Unit-II, a formulation manufacturing facility of its wholly owned subsidiary Eugia Pharma Specialities that is situated at Bhiwadi, Rajasthan.